2024, Number 4
<< Back Next >>
Rev Nefrol Dial Traspl 2024; 44 (4)
Familial Fibrillary Glomerulonephritis: A Rare Case with Histopathological Resemblance to Membranous Nephropathy
Sıla KN, Öğüt B, Gürevin S, Öz Ö, Helvacı Ö
Language: English
References: 15
Page: 205-210
PDF size: 406.72 Kb.
ABSTRACT
Fibrillary glomerulonephritis is a
rare form of glomerulonephritis,
characterized by the deposition
of haphazardly arranged fibrils
in the glomeruli, leading to renal
dysfunction. Here, we present
the first familial case of fibrillary
glomerulonephritis reported
from Türkiye, highlighting its
histopathological resemblance
to membranous nephropathy. A
45-year-old female with a family
history of kidney disease presented
with edema and was diagnosed
with fibrillary glomerulonephritis.
Immunohistochemical staining for
DNAJB9 confirmed the diagnosis. The literature
review revealed only six reported families with
familial fibrillary glomerulonephritis, suggesting
a possible autosomal dominant inheritance
pattern. Compared to previous cases, our
patient and affected family members are female
and diagnosed at ages 40-50. The patient’s
treatment involves angiotensin receptor
blockade due to non-nephrotic proteinuria
and normal renal function. The prognosis
for fibrillary glomerulonephritis is poor, and
therapeutic options are limited. Future research
should focus on understanding the genetic
basis of familial fibrillary glomerulonephritis
and developing effective treatments. This case
underscores the importance of considering
fibrillary glomerulonephritis in the differential
diagnosis of glomerulonephritis, especially in
familial cases, and highlights the need for further
studies to improve its management.
REFERENCES
Erickson SB, Zand L, Nasr SH, Alexander MP,Leung N, Drosou ME, et al. Treatment of fibrillaryglomerulonephritis with rituximab: a 12-month pilotstudy. Nephrol Dial Transplant. 2021;36(1):104-10.
Rosenstock JL, Markowitz GS. FibrillaryGlomerulonephritis: An Update. Kidney Int Rep.2019;4(7):917-22.
Andeen NK, Yang HY, Dai DF, MacCoss MJ,Smith KD. DnaJ Homolog Subfamily B Member 9Is a Putative Autoantigen in Fibrillary GN. J Am SocNephrol. 2018;29(1):231-9.
Nasr SH, Vrana JA, Dasari S, Bridoux F, Fidler ME, KaakiS, et al. DNAJB9 Is a Specific ImmunohistochemicalMarker for Fibrillary Glomerulonephritis. Kidney IntRep. 2018;3(1):56-64.
Andeen NK, Smith KD, Vasilescu ER, Batal I.Fibrillary Glomerulonephritis Is Associated WithHLA-DR7 and HLA-B35 Antigens. Kidney Int Rep.2020;5(8):1325-7.
Chan TM, Chan KW. Fibrillary glomerulonephritis insiblings. Am J Kidney Dis. 1998;31(5):E4.
Ying T, Hill P, Desmond M, Agar J, Mallett A.Fibrillary glomerulonephritis: An apparent familialform? Nephrology (Carlton). 2015;20(7):506-9.
Watanabe K, Nakai K, Hosokawa N, WatanabeS, Kono K, Goto S, et al. A Case of FibrillaryGlomerulonephritis with Fibril Deposition in theArteriolar Wall and a Family History of Renal Disease.Case Rep Nephrol Dial. 2017(1):26-33.
Andeen NK, Troxell ML, Riazy M, Avasare RS, LapasiaJ, Jefferson JA, et al. Fibrillary Glomerulonephritis:Clinicopathologic Features and Atypical Cases froma Multi-Institutional Cohort. Clin J Am Soc Nephrol.2019;14(12):1741-50.
Jeyabalan A, Batal I, Piras D, Morris HK, AppelGB. Familial Fibrillary Glomerulonephritis in LivingRelated Kidney Transplantation. Kidney Int Rep.2021;6(1):239-42.
Rosenstock JL, Markowitz GS, Valeri AM,Sacchi G, Appel GB, D’Agati VD. Fibrillary andimmunotactoid glomerulonephritis: Distinct entitieswith different clinical and pathologic features. KidneyInt. 2003;63(4):1450-61.
Raikar M, Shafiq A. Fibrillary Glomerulonephritis:A Great Mimicker of Rapidly ProgressiveGlomerulonephritis. Cureus. 2022;14(6):e26001.
Sabanis N, Liaveri P, Geladari V, Liapis G, MoustakasG. DNAJB9 Fibrillary Glomerulonephritis withMembranous-Like Pattern: A Case-Based LiteratureReview. Cureus. 2023;15(10):e47862.
Javaugue V, Karras A, Glowacki F, McGregor B,Lacombe C, Goujon JM, et al. Long-term kidneydisease outcomes in fibrillary glomerulonephritis:a case series of 27 patients. Am J Kidney Dis.2013;62(4):679-90.
Hogan J, Restivo M, Canetta PA, Herlitz LC,Radhakrishnan J, Appel GB, et al. Rituximabtreatment for fibrillary glomerulonephritis. NephrolDial Transplant. 2014;29(10):1925-31.